
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
Im Cannabis Corp (IMCC)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: IMCC (1-star) is a SELL. SELL since 5 days. Profits (51.34%). Updated daily EoD!
Year Target Price $8.22
Year Target Price $8.22
0 | Strong Buy |
0 | Buy |
1 | Hold |
0 | Under performing |
0 | Sell |
Analysis of Past Performance
Type Stock | Historic Profit 25.95% | Avg. Invested days 37 | Today’s Advisory SELL |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 8.91M USD | Price to earnings Ratio - | 1Y Target Price 8.22 |
Price to earnings Ratio - | 1Y Target Price 8.22 | ||
Volume (30-day avg) - | Beta 2.38 | 52 Weeks Range 1.29 - 7.12 | Updated Date 06/29/2025 |
52 Weeks Range 1.29 - 7.12 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.39 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -8.61% | Operating Margin (TTM) 1.26% |
Management Effectiveness
Return on Assets (TTM) -10.46% | Return on Equity (TTM) -96.83% |
Valuation
Trailing PE - | Forward PE 16.31 | Enterprise Value 19398241 | Price to Sales(TTM) 0.16 |
Enterprise Value 19398241 | Price to Sales(TTM) 0.16 | ||
Enterprise Value to Revenue 0.49 | Enterprise Value to EBITDA -1.31 | Shares Outstanding 3366970 | Shares Floating 1450440 |
Shares Outstanding 3366970 | Shares Floating 1450440 | ||
Percent Insiders 53.08 | Percent Institutions 3.87 |
Analyst Ratings
Rating 3 | Target Price 8.22 | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Im Cannabis Corp
Company Overview
History and Background
Unfortunately, there is no US publicly traded company called 'Im Cannabis Corp'. The following is a hypothetical analysis based on the assumption it's a Canadian cannabis company looking to enter the US Market.
Core Business Areas
- Cultivation and Production: Cultivation and processing of cannabis flower, oils, and extracts.
- Retail Distribution: Operation of cannabis dispensaries and online sales platforms.
- Branding and Marketing: Development and marketing of cannabis brands and products.
- Wholesale Distribution: Distribution of cannabis products to other retailers and dispensaries.
Leadership and Structure
Hypothetical Leadership: CEO with experience in cannabis operations, CFO with financial expertise, CMO for brand development. Organizational structure would likely include departments for cultivation, production, retail, marketing, and finance.
Top Products and Market Share
Key Offerings
- Dried Flower: Cannabis flower in various strains and potencies. Market share is highly fragmented, competitors include Canopy Growth (CGC), Tilray (TLRY), and Curaleaf (CURLF). Revenue would depend on market penetration.
- Cannabis Oils and Extracts: Concentrated cannabis products for vaping or ingestion. Market share depends on brand recognition and product quality. Competitors include Cronos Group (CRON) and Green Thumb Industries (GTBIF). Revenue would depend on market penetration.
- Edibles: Cannabis-infused food products. Highly competitive market with stringent regulations. Competitors include Wana Brands and Kiva Confections (privately held brands, partnerships with publicly held companies common). Revenue would depend on market penetration.
Market Dynamics
Industry Overview
The US cannabis industry is rapidly growing but fragmented with varying state regulations. There is increasing acceptance and legalization, but federal legalization remains uncertain. Significant growth potential exists, but so does regulatory risk.
Positioning
To succeed, Im Cannabis Corp would need a strong brand, efficient operations, and adherence to regulatory requirements. Competitive advantages could include unique product formulations, strong retail presence, and efficient supply chain management.
Total Addressable Market (TAM)
The US cannabis market is projected to reach over $50 billion by 2026. Im Cannabis Corp's positioning within this TAM would depend on its ability to establish a strong market presence, build brand recognition, and capitalize on growth opportunities.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Efficient cultivation and production processes
- Established retail distribution network
- Innovative product development capabilities
- Experienced management team
Weaknesses
- Limited brand awareness in the US market
- Dependence on specific geographic regions
- High operating costs
- Vulnerability to regulatory changes
- Limited capital resources compared to larger players
Opportunities
- Expansion into new US states
- Acquisition of existing cannabis businesses
- Partnerships with established retailers
- Development of new cannabis-based products
- Increased acceptance and legalization of cannabis
Threats
- Stringent regulatory requirements
- Intense competition from established players
- Fluctuations in cannabis prices
- Negative public perception of cannabis
- Potential for federal legalization to disrupt the market
Competitors and Market Share
Key Competitors
- CURLF
- GTBIF
- TRSSF
- VRNOF
- CRLBF
Competitive Landscape
Im Cannabis Corp would need to differentiate itself through unique products, strong branding, or efficient operations to compete with established players. A focus on niche markets or specific demographics could also be beneficial.
Growth Trajectory and Initiatives
Historical Growth: N/A
Future Projections: Dependent on successful market entry and expansion strategies. Analyst estimates are unavailable.
Recent Initiatives: N/A
Summary
Im Cannabis Corp, as a hypothetical US market entrant, faces a highly competitive and regulated landscape. Success hinges on building a strong brand, managing operational costs effectively, and navigating the complex regulatory environment. A strategic focus on niche markets or specific product categories could help establish a foothold. Expansion would need to be carefully managed given the need for capital and risk of rapid market shifts.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Hypothetical analysis based on industry reports and publicly available information on cannabis companies.
Disclaimers:
This analysis is for illustrative purposes only and should not be considered investment advice. The information provided is based on a hypothetical company and may not reflect the actual performance of any real-world entity. Market share estimates are approximate and subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Im Cannabis Corp
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2020-05-20 | Executive Chairman & CEO Mr. Oren Shuster | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees - | Website https://imcannabis.com |
Full time employees - | Website https://imcannabis.com |
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.